eToro - Investment and Trading Platform Home Page
SearchSearch
Languages
Language
LoginSign up
Login
Stocks-SOBI.ST-Swedish Orphan Biovitrum AB

Swedish Orphan Biovitrum AB SOBI.ST

kr275.40-4.00(-1.43%)(1D)
• Delayed prices by Stockholm Stock Exchange • In SEK
Invest in Swedish Orphan Biovitrum AB
Today
Create an eToro account to buy SOBI.ST stock on a secure, user-friendly, multi-asset trading platform.
Buy Swedish Orphan Biovitrum AB
Buy Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB SOBI.ST
Buy SOBI.ST

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

Swedish Orphan Biovitrum AB News

About Swedish Orphan Biovitrum AB
Sobi is a global biopharmaceutical company based in Stockholm, Sweden. Sobi is focused on medical solutions for rare diseases and is active in two therapeutic areas – Hematology and Immunology, in addition, the company has a portfolio of Specialty Care products.

The company’s activity spans 25 countries, delivering treatments to patients in over 70 countries across the globe. Sobi employs approximately1,300 people across Europe, the Middle East, North Africa, North America, and Russia.

Sobi’s in-house capabilities include late stage R&D, biologics manufacturing and supply, patient access and distribution, and more. The company’s immunology portfolio includes three products and is considered a leading company in treating hemophilia and providing community support in hemophilia care. In 2019, the company announced the acquisition of Dova Pharmaceuticals through a merger.

Sobi’s share is listed on Nasdaq Stockholm. The company’s financial results for the third quarter of fiscal 2019 included reported growth in revenue of 27%, reaching SEK 2,930 million. Invest in this instrument and stay updated on recent SOBI.ST value changes.
VIEW MORE   

SOBI.ST Stock Price Chart

‎3.22‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset negative trend

The Swedish Orphan Biovitrum AB share price is on the decline this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Swedish Orphan Biovitrum AB price today is kr275.40, a ‎-1.43‎% change in the last 24 hours and ‎-5.82‎% in the past week. Swedish Orphan Biovitrum AB price changed by ‎-11.05‎% in the past year.
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
-
Day’s Range
i
Shows the high and low prices of the day.
kr272.59 - kr279.38
52W Range
i
Shows the high and low prices of the last year.
kr241.03 - kr353.46
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
-
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-
Revenue
i
The total income generated by this company’s goods and services last year.
-
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
-
Prev Close
i
The final price of this asset at the end of the last trading day.
kr275.4
EPS
i
A company’s total earnings divided by the number of shares it has issued.
-
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
-
What Is Swedish Orphan Biovitrum AB?
Sobi is a global biopharmaceutical company based in Stockholm, Sweden. Sobi is focused on medical solutions for rare diseases and is active in two therapeutic areas – Hematology and Immunology, in addition, the company has a portfolio of Specialty Care products.

The company’s activity spans 25 countries, delivering treatments to patients in over 70 countries across the globe. Sobi employs approximately1,300 people across Europe, the Middle East, North Africa, North America, and Russia.

Sobi’s in-house capabilities include late stage R&D, biologics manufacturing and supply, patient access and distribution, and more. The company’s immunology portfolio includes three products and is considered a leading company in treating hemophilia and providing community support in hemophilia care. In 2019, the company announced the acquisition of Dova Pharmaceuticals through a merger.

Sobi’s share is listed on Nasdaq Stockholm. The company’s financial results for the third quarter of fiscal 2019 included reported growth in revenue of 27%, reaching SEK 2,930 million. Invest in this instrument and stay updated on recent SOBI.ST value changes.
Buy SOBI.ST

How can I buy Swedish Orphan Biovitrum AB stocks?

To purchase Swedish Orphan Biovitrum AB:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Swedish Orphan Biovitrum AB (SOBI.ST) page and place an order to buy Swedish Orphan Biovitrum AB.
Buy SOBI.ST
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2025
Top Dividend Stocks for 2025
Gear up for 2025 with these top dividend stocks. Dive into the potential of Verizon, Exxon Mobil, NextEra, Coca Cola, Unicredit through eToro’s expert analysis.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2025
AI Stocks Poised for Growth in 2025
Gear up for 2025 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Go to the Academy >
Graph
Buy Swedish Orphan Biovitrum AB
Invest in Swedish Orphan Biovitrum AB
Today
Create an eToro account to buy SOBI.ST stock on a secure, user-friendly, multi-asset trading platform.
Buy SOBI.ST

FAQ

The current price of SOBI.ST is kr275.40.
Analysts offer forecasts for Swedish Orphan Biovitrum AB based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Swedish Orphan Biovitrum AB is -
Daily Movers
Explore the biggest stocks movers on the market.
English (UK)Check icon
Deutsch
Français
Polski
Português
Dansk
Suomi
Español
Русский
العربية
Nederlands
Svenska
Română
Italiano
中文
繁體中文
Norsk
Čeština
Tiếng Việt
Scroll to top